Axa S.A. Zai Lab LTD Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Zai Lab LTD stock. As of the latest transaction made, Axa S.A. holds 65,814 shares of ZLAB stock, worth $1.44 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,814

Previous 65,814 -0.0%

Holding current value

$1.44 Million

Previous $2.38 Million 3.24%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.72 - $21.55 $125,208 - $196,665	-9,126 Reduced 12.18%	65,814 $1.14 Million
Q1 2024 May 15, 2024	SELL	$15.95 - $26.8 $1.29 Million - $2.17 Million	-80,835 Reduced 51.89%	74,940 $1.2 Million
Q4 2023 Jul 16, 2024	BUY	$22.97 - $30.58 $1.86 Million - $2.47 Million	80,835 Added 107.87%	155,775 $4.26 Million
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $297,208 - $395,674	-12,939 Reduced 7.67%	155,775 $4.26 Million
Q3 2023 Nov 14, 2023	SELL	$22.72 - $31.49 $3.46 Million - $4.8 Million	-152,330 Reduced 47.45%	168,714 $4.1 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $363,105 - $569,343	14,352 Added 4.68%	321,044 $8.9 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $313,761 - $499,566	10,386 Added 3.51%	306,692 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $904,857 - $1.57 Million	40,613 Added 15.88%	296,306 $9.1 Million
Q3 2022 Feb 14, 2023	BUY	$34.2 - $51.69 $2.08 Million - $3.14 Million	60,692 Added 31.12%	255,693 $8.74 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $2.08 Million - $3.14 Million	60,692 Added 31.12%	255,693 $8.75 Million
Q2 2022 Feb 14, 2023	SELL	$23.14 - $49.68 $1.4 Million - $3.02 Million	-60,692 Reduced 23.74%	195,001 $6.76 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $4.51 Million - $9.69 Million	195,001 New	195,001 $6.76 Million
Q1 2022 May 13, 2022	SELL	$27.77 - $64.4 $9.41 Million - $21.8 Million	-338,991 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $5.28 Million - $10.1 Million	96,151 Added 39.59%	338,991 $21.3 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $656,670 - $1.12 Million	6,254 Added 2.64%	242,840 $25.6 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $11.2 Million - $16 Million	89,127 Added 60.44%	236,586 $41.9 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $18.6 Million - $28.3 Million	147,459 New	147,459 $19.7 Million
Q4 2020 Feb 12, 2021	SELL	$81.94 - $135.34 $10.9 Million - $18 Million	-133,054 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$73.3 - $89.48 $1.17 Million - $1.43 Million	-15,938 Reduced 10.7%	133,054 $11.1 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $303,660 - $513,336	-6,220 Reduced 4.01%	148,992 $12.2 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $3.08 Million - $4.95 Million	-78,716 Reduced 33.65%	155,212 $7.99 Million
Q4 2019 Feb 18, 2020	BUY	$29.79 - $43.06 $1.72 Million - $2.48 Million	57,691 Added 32.73%	233,928 $9.73 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $946,641 - $1.17 Million	31,068 Added 21.4%	176,237 $5.7 Million
Q2 2019 Aug 13, 2019	BUY	$25.73 - $35.79 $3.74 Million - $5.2 Million	145,169 New	145,169 $5.06 Million

Others Institutions Holding ZLAB

# of Institutions

167

Shares Held

37.6M

Call Options Held

150K

Put Options Held

201K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.14B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account